Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

EGX:CPCI Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	51.04	246.11	97.09	165.74	124.3	109.14
Depreciation & Amortization	19.84	19.84	15.94	-	-	0.65
Other Amortization	0.01	0.01	0.01	-	-	-
Other Operating Activities	72.59	-3.08	-24.52	-113.92	37.95	-131.75
Operating Cash Flow	143.49	262.89	88.53	51.83	162.25	-21.96
Operating Cash Flow Growth	-26.13%	196.96%	70.82%	-68.06%	-	-
Capital Expenditures	-196.07	-243.54	-79.07	-17.31	-23.68	-8.34
Sale of Property, Plant & Equipment	-0.55	-	0.08	0	0.04	-
Investment in Securities	-	-0.84	-	15.86	-14.11	14.47
Other Investing Activities	21.64	12.8	2.85	4.94	2.62	2.28
Investing Cash Flow	-174.98	-231.58	-76.14	3.49	-35.13	8.41
Long-Term Debt Issued	-	133.88	144.31	-	-	-
Long-Term Debt Repaid	-	-50.76	-28.36	-	-	-
Net Debt Issued (Repaid)	-50.87	83.12	115.95	-	-	-
Common Dividends Paid	-184.78	-85.53	-100.82	-75.2	-77.73	-54.95
Financing Cash Flow	-235.65	-2.41	15.13	-75.2	-77.73	-54.95
Miscellaneous Cash Flow Adjustments	-0	-	-	-	-	-
Net Cash Flow	20.59	28.9	27.51	-19.89	49.39	-68.5
Free Cash Flow	-52.58	19.35	9.45	34.52	138.57	-30.3
Free Cash Flow Growth	-	104.69%	-72.61%	-75.09%	-	-
Free Cash Flow Margin	-2.86%	1.42%	0.94%	3.10%	13.05%	-3.00%
Free Cash Flow Per Share	-3.52	1.30	0.63	2.31	9.28	-2.03
Cash Interest Paid	20.21	20.21	5.85	-	-	-
Cash Income Tax Paid	45.89	45.89	73.12	51.33	36.22	36.35
Levered Free Cash Flow	174.5	-55.03	57.94	-20.17	97.35	-51.72
Unlevered Free Cash Flow	182.02	-43.19	60.12	-20.17	97.35	-51.72
Change in Net Working Capital	-45.63	-1.94	-75.27	122.91	-23.32	130.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.